TRANSCENTA HOLDING - A Global Fully Integrated Biotherapeutics Company
Transcenta, Biologics, Antibody, Claudin 18.2
Transcenta’ s GMP production facility in Hangzhou Biopharma Town is designed with a modular concept with independent intellectual property rights. The modular GMP facility, which we refer to as T-BLOC, offers high flexibility and scalability. The whole production process adopts disposable technology, which can effectively avoid the risk of cross-contamination in the simultaneous production of multiple products.
Its current capability include DS and DP manufacturing for Toxicology Studies, Phase I, Phase II and Phase III clinical trials with planned manufacturing of commercial products up to 1000kg protein annual output.